Cancer places 100b-yuan strain on China’s economy
Cancer cases are rising rapidly in China and are estimated to cost the country 100 billion yuan ($15 billion) a year, according to health organizations and experts.
The World Health Organization, marking World Cancer Day, which falls on Feb 4, said more than 3 million Chinese develop cancer each year and 2.2 million of them die.
In large cities like Beijing, the average medical cost for each cancer patient is up to 300,000 yuan. Many patients abandon treatment because they cannot afford it.
“(The 100 billion yuan)
is definitely an underestimate, but cancer is on the rise, for sure,” said Wang Jinwan, a physician at the Chinese Academy of Medical Sciences’ Cancer Institute and Hospital.
Chen Wanqing, director of the National Central Cancer Registry under the National Health and Family Planning Commission, said deaths from the disease place not only a burden on patients’ families but also on the national economy, to the tune of more than 100 billion yuan a year.
Lung cancer is the most common type diagnosed among Chinese men and the leading cause of cancer deaths in China. Among women in the country, breast cancer is the type most commonly diagnosed and one of the deadliest.
Bernhard Schwartlander, the WHO representative in China, said, “The growth of cancer in China is ferocious. We must do all that we can to prevent cancer and spare as many Chinese families as possible the heartache, pain, suffering and financial hardship of a cancer diagnosis.”
He mentioned Chinese singer Yao Beina who died from breast cancer on Jan 16 at age 33.
He suggested that all women should perform regular selfexaminations of their breasts, consult their healthcare providers to ensure they are using correct techniques, and talk to their doctors immediately if they notice any abnormalities.
He attaches great importance to early detection, saying awareness is the first step to early detection and improving cancer outcomes.
Early-stage cancers are less lethal and more treatable than late-stage cases, he added.
Cheng Shujun, a cancer specialist in Beijing and an academic at the Chinese Academy of Engineering, said China’s five-year cancer survival rate stands at 30 percent, far lower than 70 percent in the US.
Schwartlander said, “Improving early diagnosis and treatment services must continue to be a focus of cancer control efforts, given that twothirds of cancer cases are not preventable.”
For those that are preventable, “improving cancer prevention in China would save many millions of lives every year,” he added.